Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Animalcare Group's share price for the quarter that ended in Dec. 2023 was £1.7. Animalcare Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 60.11 Mil. Therefore, Animalcare Group's market cap for the quarter that ended in Dec. 2023 was £102.18 Mil.
Animalcare Group's quarterly market cap
declined
from Dec. 2022 (£136.71 Mil) to Jun. 2023 (£109.08 Mil) and
declined
from Jun. 2023 (£109.08 Mil) to Dec. 2023 (£102.18 Mil).
Animalcare Group's annual market cap
declined
from Dec. 2021 (£207.32 Mil) to Dec. 2022 (£136.71 Mil) and
declined
from Dec. 2022 (£136.71 Mil) to Dec. 2023 (£102.18 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Animalcare Group's Enterprise Value for Today is £148.55 Mil.
Animalcare Group Market Cap Historical Data
The historical data trend for Animalcare Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Animalcare Group's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Animalcare Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Animalcare Group's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Animalcare Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Animalcare Group's Market Cap falls into.
Animalcare Group Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Animalcare Group's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Animalcare Group (LSE:ANCR) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Animalcare Group Market Cap Related Terms
Thank you for viewing the detailed overview of Animalcare Group's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. Its only reportable segment is Pharmaceutical which includes the development and marketing of innovative pharmaceutical products. The company has a presence in Belgium, The Netherlands, Germany, Italy, Portugal, European Union - Other, Asia, Middle East Africa, Spain, the United Kingdom, and Other Countries of which Spain derives a majority of revenue to the company.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:ANCR has been successfully added to your 